Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Clinical activity of folinic acid in patients with chronic fatigue syndrome.

Lundell K, Qazi S, Eddy L, Uckun FM.

Arzneimittelforschung. 2006;56(6):399-404.

PMID:
16889122
2.
3.

Prevalence of abnormal cardiac wall motion in the cardiomyopathy associated with incomplete multiplication of Epstein-barr Virus and/or cytomegalovirus in patients with chronic fatigue syndrome.

Lerner AM, Dworkin HJ, Sayyed T, Chang CH, Fitzgerald JT, Beqaj S, Deeter RG, Goldstein J, Gottipolu P, O'Neill W.

In Vivo. 2004 Jul-Aug;18(4):417-24.

4.
5.

Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.

Joncas JH, Wills A, Reece E, Fox Z.

Can Med Assoc J. 1981 Oct 15;125(8):845-9.

6.

Epstein-Barr virus (EBV) and the chronic fatigue syndrome: normal virus load in blood and normal immunologic reactivity in the EBV regression assay.

Swanink CM, van der Meer JW, Vercoulen JH, Bleijenberg G, Fennis JF, Galama JM.

Clin Infect Dis. 1995 May;20(5):1390-2.

PMID:
7620030
7.
8.

Serologic and virologic epidemiology of Epstein-Barr virus: relevance to chronic fatigue syndrome.

Sumaya CV.

Rev Infect Dis. 1991 Jan-Feb;13 Suppl 1:S19-25. Review.

PMID:
1850540
9.

Antibodies to Epstein-Barr virus in patients with chronic fatigue.

Matthews DA, Lane TJ, Manu P.

South Med J. 1991 Jul;84(7):832-40. Review.

PMID:
1648795
10.
11.

Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome.

Cameron B, Flamand L, Juwana H, Middeldorp J, Naing Z, Rawlinson W, Ablashi D, Lloyd A.

J Med Virol. 2010 Oct;82(10):1684-8. doi: 10.1002/jmv.21873.

PMID:
20827765
12.

Epstein-Barr virus in pediatric patients after renal transplantation.

Schwab M, Böswald M, Korn K, Ruder H.

Clin Nephrol. 2000 Feb;53(2):132-9.

PMID:
10711415
13.

Severe chronic active Epstein-Barr virus infection syndrome and adenovirus type-2 infection.

Okano M, Thiele GM, Purtilo DT.

Am J Pediatr Hematol Oncol. 1990 Summer;12(2):168-73.

PMID:
2165745
14.
15.

Antibodies to Epstein-Barr virus-specific DNase and DNA polymerase in the chronic fatigue syndrome.

Jones JF, Williams M, Schooley RT, Robinson C, Glaser R.

Arch Intern Med. 1988 Sep;148(9):1957-60.

PMID:
2843138
16.

Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection.

Tsuge I, Morishima T, Kimura H, Kuzushima K, Matsuoka H.

J Med Virol. 2001 Jun;64(2):141-8.

PMID:
11360246
17.

Serum IgA antibodies to Epstein-Barr virus (EBV) early lytic antigens are present in primary EBV infection.

Bhaduri-McIntosh S, Landry ML, Nikiforow S, Rotenberg M, El-Guindy A, Miller G.

J Infect Dis. 2007 Feb 15;195(4):483-92. Epub 2007 Jan 10.

PMID:
17230407
18.
20.

Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.

Blaschke S, Schwarz G, Moneke D, Binder L, Müller G, Reuss-Borst M.

J Rheumatol. 2000 Apr;27(4):866-73.

PMID:
10782808

Supplemental Content

Support Center